Anna Hagstrom

Q: What is Anna Hagstrom email address?

Email Anna Hagstrom at anna.e.v.hagstrom@gmail.com and anna.hagstrom@astrazeneca.com. This email is the most updated Anna Hagstrom email found in 2026.

Q: How to contact Anna Hagstrom?

To contact Anna Hagstrom send an email to anna.e.v.hagstrom@gmail.com or anna.hagstrom@astrazeneca.com. If you want to call Anna Hagstrom try calling on +13013982861.

Director at AstraZeneca | Washington DC-Baltimore Area

About Anna Hagstrom

As the Director and Head of the Downstream team for Clinical Biologics at AstraZeneca, Anna Hagstrom exemplifies a unique blend of scientific expertise and strategic leadership. With a robust background in biotechnology and a deep understanding of process development, Anna has been instrumental in advancing the company's capabilities in the production of antibody drug conjugates (ADCs). Her extensive knowledge of cGMP manufacturing, both clinical and commercial, ensures that AstraZeneca maintains the highest standards of quality and compliance throughout the development process.

Anna’s leadership style is characterized by her strong communication skills and her ability to foster collaboration among cross-functional teams. She is dedicated to mentoring her team members, encouraging a culture of continuous learning and development. This commitment not only enhances team performance but also drives innovation in protein purification techniques and biocatalysis processes. Under her guidance, the Downstream team has successfully implemented Design of Experiments (DoE) and Quality by Design (QbD) principles, optimizing workflows and improving product yield.

In addition to her leadership role, Anna is a published author with fourteen papers in peer-reviewed journals, showcasing her commitment to advancing scientific knowledge within the field. Her research contributions and insights into antibody characterization and ELISA methodologies have positioned her as a thought leader in the industry. With a passion for pushing the boundaries of biotechnology, Anna Hagstrom continues to play a pivotal role in AstraZeneca's mission to deliver innovative therapies that improve patient outcomes.

Anna Hagstrom Work